MI efficiently inhibits bladder cancer progression both in vitro and in vivo by inhibiting the Nox4/NF-κB/HIF-1α signaling pathway by directly upregulating miR-26b expression, suggesting that MI might be a potential anticancer agent for bladder cancer. This evidence concerns the gene NFKB1 and urinary bladder carcinoma.